Unveiling Role of MicroRNAs in Metastasizing Triple Negative Breast Cancer : From Therapeutics to Delivery

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

Triple negative breast cancers are malignant, heterogeneous tumors with high histological grades, increased reoccurrence, and cancer-related death rates. TNBC metastasis to the brain, lungs, liver, and lymph nodes is a complex process regulated by epithelial to mesenchymal transition, intravasation, extravasation, stem cell niche, and migration. Aberrant expression of miRNAs, also known as a transcriptional regulators of genes, may function as oncogenes or tumor suppressors. In this review, we systematically elucidated the biogenesis and tumor suppressor role of miRNA in targeting distant metastasis of TNBC cells and the above-mentioned underlying mechanisms involved in complicating the disease. Apart from their therapeutic implications, the emerging roles of miRNAs as prognostic markers have also been discussed. To overcome delivery bottlenecks, RNA nanoparticles, nano-diamonds, exosomes, and mesoporous silica nanoparticle-mediated delivery of miRNAs have been contemplated. Altogether, the present review article uncovers the potential role of miRNA in antagonizing distant metastasis of TNBC cells, and highlights their clinical significance as prognostic markers and possible drug delivery strategies to enhance the likely outcome of miRNA-based therapy against the disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

Current drug targets - 24(2023), 6 vom: 09., Seite 509-520

Sprache:

Englisch

Beteiligte Personen:

Balkrishna, Acharya [VerfasserIn]
Mittal, Rashmi [VerfasserIn]
Arya, Vedpriya [VerfasserIn]

Links:

Volltext

Themen:

Delivery
Journal Article
Metastasis
MiRNAs
MicroRNAs
Prognosis
Review
Stem cells
Therapeutics

Anmerkungen:

Date Completed 19.06.2023

Date Revised 16.11.2023

published: Print

Citation Status MEDLINE

doi:

10.2174/1389450124666230308154551

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35397742X